HHealthcare Read More Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7BApril 20, 2026 Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…
HHealthcare Read More Eli Lilly in advanced talks to acquire Kelonia Therapeutics: WSJApril 20, 2026 Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
HHealthcare Read More Lilly’s obesity pill helps reduce cardiovascular risks in late-stage trialApril 16, 2026 Eli Lilly Foundayo GLP-1 weight loss pill. Courtesy: Eli Lilly Eli Lilly said on Thursday its newly approved…
AArtificial intelligence Read More Novo Nordisk partners with OpenAI as AI drug discovery hopes mount April 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
HHealthcare Read More Lilly seals up to $7.8 billion deal for Centessa in sleep disorder betMarch 31, 2026 Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
AArtificial intelligence Read More Eli Lilly reaches deal to bring AI-developed drugs to global marketMarch 29, 2026 A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…
HHealth Read More Every Cure’s drug repurposing could change rare disease treatmentMarch 27, 2026 Dr. David Fajgenbaum, one of the founders of Every Cure, a nonprofit focused on drug repurposing. Courtesy of…
MMedication Read More FDA approves high dose version of Novo Nordisk’s obesity drug WegovyMarch 22, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
HHealthcare Read More Vertex kidney drug povetacicept succeeds in trial for IgANMarch 10, 2026 A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters…
BBusiness Read More Zealand stock plummets after trial setback, CEO remains optimisticMarch 7, 2026 Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management…
HHealthcare Read More Eli Lilly launches program to boost employer coverage of obesity drugsMarch 5, 2026 Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
HHealthcare Read More Why Novo Nordisk’s Ireland expansion is key to fighting off Eli LillyMarch 2, 2026 Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…